VistaGen Therapeutics, Inc. (VTGN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for VistaGen Therapeutics, Inc., with annual and quarterly history.
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.31x | -1.49x | -3.56x | -0.42x | -5.14x | -10.23x |
| P/B Ratio | 0.61x | 1.09x | 0.91x | 2.07x | 3.79x | 1.99x |
| P/S Ratio | 17.15x | 157.98x | 98.23x | -110.36x | 221.38x | 168.39x |
| Profitability | ||||||
| Gross Margin | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -5683.7% | -11517.1% | -3103.5% | 26109.3% | -4308.7% | -1646.1% |
| Net Margin | -5491.3% | -10579.8% | -2759.6% | 26100.4% | -4307.2% | -1646.1% |
| EBITDA Margin | -5683.7% | -11386.4% | -3050.1% | 25874.9% | -4242.8% | -1600.8% |
| Liquidity | ||||||
| Current Ratio | 3.67x | 6.51x | 23.55x | 3.83x | 12.32x | 24.85x |
| Quick Ratio | 3.67x | 6.51x | 23.55x | 3.83x | 12.32x | 24.85x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.02x | 0.02x | 0.22x | 0.05x | 0.04x |
YoY = year-over-year change. Source: FMP..